AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04278898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine
Description: N-acetylcysteine Single Dose 2700 mg taken orally
Study NCT05238818 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Tumor Infiltrating Lymphocyte Injection (GT202)
Description: A tumor sample is resected from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. T cells then are manufactured to express mbIL-12. After lymphodepletion, patients are infused with GT202 followed by IL-2.
Study NCT05252923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulodexide
Description: Sulodexide 250 LSU 1 oral capsule twice daily for 8 weeks
Study NCT04839536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalant product
Description: Sevoflurane will be delivered in an incremental dose to throughout procedure to achieve clinical sedation endpoint OAAS 3.
Study NCT06396702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EASE-SOT
Description: EASE integrates supportive counseling and trauma-focused cognitive behavioral therapy (CBT) (EASE-psy) with systematic physical symptom screening and triggered referral to supportive care to manage moderate to severe physical symptoms (EASE-phys) using electronic patient reported outcome measures (ePROMs). The intervention duration is 8 weeks. Based on individual preference, EASE-psy may be administered in person or virtually via Microsoft Teams. Based on individual preference, participants may receive ePROMs either on tablets or to their personal electronic devices via email, while at the hospital ward and in clinics, ensuring easy access and administration of these tools.
Study NCT04945525 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care Continuity Program
Description: The Care Continuity Program is an online patient self-assessment tool used by prescribers of opioids to better identify patient risk factors and opioid therapy benefit. This tool is completed by the patient, outside of the office, using an internet enabled device and follows a compliance driven protocol developed by analyzing case law against physicians in mis-prescribing opioid cases. Results, in the form of a date and time stamped legal report, are instantly transmitted to the prescriber's electronic health records, mitigating the prescriber's civil and criminal risk. A brief of findings is displayed within the software through a dashboard and on the summary page of the report. Prescribers may use the summary page to help them identify the appropriateness of initiating opioid therapy and/or continuing opioid therapy.
Study NCT05843331 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implants
Description: Four implants in the maxilla with locator attachments
Study NCT04698070 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional Strategy - OptiMA
Description: All children randomized to this arm will be treated with a RUTF, with weekly ration determined according to MUAC, weight and presence of nutritional edema. Ration will be adjusted weekly according to the change in MUAC and weight throughout the outpatient follow-up until the child achieves nutritional recovery.~RUTF dosage will 170 kcal/kg/d for the most severely wasted (MUAC \< 115 mm or edema) and reduced to 125 kcal/kg/d for children with MUAC 115-119mm and 75 kcal/kg/d for children with MUAC 120-124 mm.~All children will be followed-up for 6 months following randomization. They will have weekly outpatient visit in the health facility until they meet nutritional recovery criteria, and then a monthly community-based follow-up in their villages (vital status, anthropometric measures and clinical condition). Referral to the health facility for appropriate nutritional/medical care if illness or acute malnutrition relapse detected).
Study NCT04698070 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional Strategy - ComPAS
Description: All children randomized to this arm will be treated with RUTF, with weekly ration determined according to MUAC and presence of nutritional edema. Children enrolled with MUAC \< 115 mm or edema will receive 1000 kcal/d (2 sachets/day) RUTF until MUAC has surpassed 115 mm and/or edema is resolved for 2 weeks at which time ration will be reduced to 500 kcal/d (1 sachet/day) until MUAC > or = to 125 mm is achieved for 2 consecutive weeks. Children enrolled with MUAC 115-124 mm will receive 1 sachet/day until MUAC > or = 125 mm is achieved for 2 consecutive weeks and clinically well. Following nutritional recovery, a study nurse will conduct monthly community-based follow-up in their villages (vital status, anthropometric measures and clinical condition) with referral to the health facility for appropriate nutritional/medical care if illness or acute malnutrition relapse detected) for the remainder of the 6 month period following inclusion.
Study NCT04698070 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: National nutritional Strategy (Niger)
Description: Different protocols for SAM and MAM comprise the Niger National Nutrition Protocol:~1. SAM: Children with MUAC\<115 or WHZ\<-3 or nutritional edema, will be treated with RUTF, according to a dosage table based on weight at each visit.~2. MAM: Children aged between 6-24 months with MUAC between 115 -124 mm and WHZ>-3 will be treated with RUSF. Children with the same anthropometry but age 24-59 m will only receive supplementation if they develop criteria for SAM during the 6 month study period. They will be monitored via monthly home visits by a study nurse.~All children will be followed-up for 6 months following randomization. Children eligible for RUTF at randomization will have a weekly outpatient visit in the health facility until they meet discharge criteria, and then a bi-monthly community-based follow-up in their villages (vital \& anthropometric status and referral to the health facility for appropriate nutritional/medical care if indicated).
Study NCT06286332 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: 30 minutes of self-selected music playback every day.
Study NCT06460870 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mojzisova method
Description: The home based regular exercises stretching and strengthning exercises twice daily along with hot pack. Manual therapy was applied in the first half of the menstrual cycle, once a month, for one hour. It includes mobilization of ribs, lumbar spine, and sacroiliac joints as well as coccygeal treatment, and internal rectal work. The patient was received 2 sessions per month for 3 months, for 45 minutes.
Study NCT06460870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching exercises
Description: Stretching exercises was performed such as cobra pose, cat/cow pose and baby pose along with hotpack for 2 sessions per month for 45 min for 3 months.
Study NCT04679038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1701
Description: Intravenous (IV) on Day 1 of each cycle
Study NCT04679038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famitinib
Description: Famitinib, po, qd
Study NCT04524221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTG-100
Description: PTG-100, 600mg taken twice daily in capsule form for 42 days
Study NCT04524221 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo taken twice daily in capsule form for 42 days
Study NCT05086965 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Playing the virtual game simulation
Description: The virtual game simulation developed by the researchers and designed by the researchers will be played on the computer for the students of the intervention group. Virtual game simulations are virtual games developed by researchers, specific to a clinical scenario, and prepared by transferring the videos taken with an action camera to the computer environment and displaying them in two dimensions.
Study NCT05672368 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Surgery
Description: Undergo surgery using the da Vinci SP device
Study NCT05461586 — intervention group
Intervention type: DEVICE
Intervention: Refractive Technique (MR #1)
Description: Fogging method that employs fogging lens to ensure there is sufficient visual defocus to induce blur.
Study NCT05461586 — intervention group
Intervention type: DEVICE
Intervention: Refractive Technique (MR #2)
Description: Duochrome method that employs the chromatic aberration of the eye, with the shorter wavelengths (green) focused in front of the longer (red) wavelengths
Study NCT04690218 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hospital anxiety and depression scale
Description: Self assessment scale suitable for hospital community as well as public community. Applying the scale does not require any psychopathologic training.
Study NCT04690218 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pittsburgh Sleep Quality Index
Description: Self assessment scale for public community. Applying the scale does not require any specially trained personnel.
Study NCT04690218 — intervention group
Intervention type: BEHAVIORAL
Intervention: Nutritional Status Questionnaire
Description: It consists of 26 items, questioning the frequency and amount of certain nutritional elements (ones known to worsen and benefit mastalgia) consumed by the individual.
Study NCT04839536 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane inhalant product
Description: Sevoflurane will be delivered in an incremental dose to throughout procedure to achieve clinical sedation endpoint OAAS 3.
Study NCT05725330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gamification and education with mobile game application
Description: This study aimed to provide self-care management by playing mobile games to patients with type 2 diabetes.
Study NCT04771143 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFQ056
Description: oral administration
Study NCT04771143 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo for oral administration
Study NCT05694663 — intervention group
Intervention type: DEVICE
Intervention: Vivistim
Description: After one month of prehabiliatory training, the patient will then undergo surgical placement of the implantable VNS device (Vivistim System) consisting of an implantable neurostimulator and an implantable lead and electrode per standard of care. The device comes with a controller and software system which allows for control of the stimulation settings during the rehabilitation phase. The PMA number for this device is 210007 and the date of FDA notice of approval occurred on August 27, 2021.
Study NCT05807412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PrabotulinumtoxinA-Xvfs
Description: All subjects will receive one injection of 4 units or 0.1 cc of prabotulinumtoxin A into the frontalis at a single point 2.5 cm above the orbital rim at the mid-pupillary line.~The preparation of the 100-unit vial of prabotulinumtoxinA will be reconstituted gently and without shaking with 2.5 cc of 0.9% preserved normal saline solution. The investigator performing the injections will reconstitute study vials.~Subjects will be injected intramuscularly using a hubless tuberculin syringe. Injections will be done at a 90-degree angle or perpendicular to the skin surface. The target sites will be the mid-line of the pupil and 2.5 cm above the orbital rim.
Study NCT05807412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OnabotulinumtoxinA
Description: All subjects will receive one injection of 4 units or 0.1 cc of onabotulinumtoxinA into the frontalis at a single point 2.5 cm above the orbital rim at the mid-pupillary line.~The preparation of the 100-unit vial of onabotulinumtoxinA will be reconstituted gently and without shaking with 2.5 cc of 0.9% preserved normal saline solution. The investigator performing the injections will reconstitute study vials.~Subjects will be injected intramuscularly using a hubless tuberculin syringe. Injections will be done at a 90-degree angle or perpendicular to the skin surface. The target sites will be the mid-line of the pupil and 2.5 cm above the orbital rim.
Study NCT05468281 — intervention group
Intervention type: OTHER
Intervention: Checklist implementation
Description: . Our strategies will include a) selection of local physician champions from the ED and cardiology; b) discussion of the goals of the study with the local physician groups; c) formal introduction of the CAEP Checklist to the physicians and nurses by means of presentations at staff meetings, emails, and an online video; d) development of an action plan to address local barriers to implementation; e) creation of a free smartphone application; f) regular reminders; and g) and distribution of charts of site compliance.
Study NCT05302427 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Infant Massage
Description: The training will start with a leg massage in the first session and the mother will be asked to do this once a day until the next lesson. The next week, the new massage movement will be shown to the mother and the training will continue, and the mother will be told to do the application throughout the week by integrating it with the previous movement this time, and the four-week training will be completed in this way. After the training, which massage movement was taught to the mothers every week, the application pictures of this part will be sent and at the end of the four-week training, the baby massage video and the baby massage guide will be sent to the mothers by e-mail.
Study NCT03856736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIAT
Description: Moderated aerobic exercise
Study NCT03856736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Weekly body relaxation and sham group
Study NCT04618029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Modification
Description: Home Modification Intervention~Floor~Provide recommendations to:~* Fix the back of the rugs and mats with adhesive/heavy duty tape~* Buy non-slip mats~* Tie all cables with a proper cable tie~Lighting~Provide recommendations to:~* Buy a torch light~* To replace worn light bulbs~* Buy a light switch~Bathroom~Provide recommendations to:~* Buy a non-slip mat~* Install a grab rail~* Buy a commode chair for showering~Stairways~Provide recommendations to:~• Fix an adhesive tape for stair contrast
Study NCT04618029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: Techniques Description Energy Conservation~* Take your time~* Go to the toilet more often, so you don't have to rush~* Use a nearby toilet: commode, different bathroom~* Prepare ahead (e.g., toilet paper near, other items for toileting, etc.)~* Adjust equipment before changing position~* Avoid transfers when tired~* Ask for help if you feel sick or especially tired~* Allow time for eyes to adjust to change in lighting~Task Simplification~* Plan and organise workspaces to eliminate unnecessary steps, save time, energy and reduce fatigue.~* Prioritise and plan activities, alternating between active and quiet jobs and include rest periods.~Ergonomics~* Proper positioning while doing tasks~* Safe mobility around the home
Study NCT06462287 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aprepitant 125 and 80Mg Oral Capsule
Description: Aprepitant 1 oral capsule time a day for 4 days (First day: 125 mg and the 3 last days: 80 mg)
Study NCT06462287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo:1 oral capsule time a day for 4 days
Study NCT04758481 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: primary tumour radiotherapy
Description: The study subjects will undergo primary tumour radiotherapy.
Study NCT04758481 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic body radiotherapy
Description: The study subjects will undergo stereotactic body radiotherapy.
Study NCT04758481 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: maintenance radiotherapy
Description: The study subjects will undergo maintenance radiotherapy.
Study NCT05938348 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: angiopuncture
Description: we conducted acupuncture on perforators by using acupuncture needles.
Study NCT05654220 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text Messaging Intervention
Description: A text messaging intervention will be conducted that includes prompts to call trained BenePhilly enrollment specialists to submit applications for benefits programs. Text message prompts will be sent on days 2, 4, 7, 14, and 21 post-discharge from a Penn Medicine emergency department.
Study NCT05985837 — intervention group
Intervention type: DEVICE
Intervention: KalobaGOLA spray (1)
Description: Oral spray, 2-4 spray, till 8 times per day
Study NCT05985837 — intervention group
Intervention type: DEVICE
Intervention: KalobaGOLA spray (2)
Description: Oral spray, 2-4 spray, till 4 times per day
Study NCT05985837 — intervention group
Intervention type: DEVICE
Intervention: KalobaGOLA tablets
Description: 1 tablets, 6 times per day
Study NCT05163301 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relapse Prevention Intervention
Description: 2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder
Study NCT05280821 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: daily ferrous sulfate
Description: Daily intake of 100 mg ferrous sulfate capsules for 3 months
Study NCT05280821 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: alternate day ferrous sulfate
Description: Alternate day intake of 100 mg ferrous sulfate capsules for 6 months
Study NCT05543642 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hepatitis A vaccine
Description: Vaccination series administered to prevent hepA infection.
Study NCT00988793 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic distal pancreatectomy
Description: Comparison of two different types of surgery, laparoscopic versus distal pancreatectomy
Study NCT00988793 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open distal pancreatectomy
Description: Comparison of two different types of surgery, open versus laparoscopic distal pancreatectomy.
Study NCT05257928 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CARE-CITE Gait
Description: The CARE-CITE intervention content modified to address gait rehabilitation, and test 4-weeks of CARE-CITE-Gait in 15 CP/SS dyads.It will occur in the dyad's home.CP will complete 6 online CARE-CITE modules. Modules will include demonstration videos and instructive content covering the following areas:principles of functional task practice, the adaptation of tasks, and importance of progression of challenging tasks to drive neuroplasticity. Examples are provided to address potential SS frustration and improve adherence.Underpinning the content is the concept of autonomy support,with examples of fostering empathy, problem-solving, instruction in the use of non-controlling language with role-playing situations and the importance of creating choice in activities. During the two home therapy sessions, the physical therapist will work with the CP and stroke survivor to collaboratively develop goals and an exercise program to improve mobility, gait and balance.
Study NCT05543642 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Diphtheria, pertussis, and tetanus booster vaccine
Description: Vaccination booster administered to prevent diphtheria, pertussis, and tetanus
Study NCT05036161 — intervention group
Intervention type: OTHER
Intervention: Nasal high flow
Description: Newborns with respiratory distress treated with NHF.
Study NCT05036161 — intervention group
Intervention type: OTHER
Intervention: Continuous Positive Airway Pressure
Description: Newborns with respiratory distress treated with CPAP.
Study NCT06271694 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Vestibular Rehabilitation
Description: Standard vestibular rehabilitation
Study NCT06197737 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Interval Training
Description: Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.
Study NCT06197737 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training
Description: sprint interval training in which they will do stair climbing 3 times a week with a fast pace.
Study NCT06169618 — intervention group
Intervention type: OTHER
Intervention: cervical radiculopathy
Description: this group will have patients with cervical radiculopathy
Study NCT06169618 — intervention group
Intervention type: OTHER
Intervention: normal group
Description: this group will have normal subjects
Study NCT06197737 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: pharmacological treatment
Description: They will be on pharmacological treatment as prescribed by their pulmonologist.
Study NCT04976998 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: imaging
Description: imaging by ultrasonography and nerve conduction studies will be done for both grups
Study NCT05354570 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Pleural Radiation Therapy (IMPRINT)
Description: Radiation therapy will be administered over approximately 6 weeks at 50.4 Gy in 28 fractions, including an optional dose-painting SIB to gross residual disease up to 60 Gy while respecting normal tissue constraints.
Study NCT05551455 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Nutritional/dietary intake manipulation ('Normal')
Description: Energy Intake provision (60 kcal/kg FFM/day) to elicit 'normal' energy availability (45 kcal/kg FFM/day), with 60% from carbohydrates.
Study NCT05551455 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional/dietary intake manipulation ('Low')
Description: Energy Intake provision (60 kcal/kg FFM/day), with 1.5 g/kg of carbohydrate and 70-80% fat intake, to elicit 'low' carbohydrate availability in energy balance (45 kcal/kg FFM/day).